Drugs / Cattle Encephalon Glycoside and Ignotin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03546283 | Jun 2018 → Jul 2020 | intracerebral hemorrhage | Rong Hu, MD | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cattle Encephalon Glycoside and Ignotin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03546283 ↗ |
| Known as | CEGI | “Cattle encephalon glycoside and ignotin Cattle encephalon glycoside and ignotin (CEGI) injection (drug approval H22025046; Jilin Sihuan Pharmaceutical Co. LTD., Jilin, People's...” NCT03546283 ↗ |
| Modality | Other / unclassified | “is a compound preparation of muscle extract from healthy rabbits and cattle brain gangliosides” NCT03546283 ↗ |